98%
921
2 minutes
20
Objective: To evaluate visual impairment (VI) at presentation in pediatric uveitis cases in southern and eastern India.
Methods: Retrospective analysis of 477 children across four tertiary centers (2015-2020). Best-documented visual acuity (ETDRS letters) in the better eye was used to categorize VI.
Results: Mean age at presentation was 11 ± 3.7 years; 43.8% were females, and 64.8% bilateral. Of 205 patients with complete investigations, 32.7% were undifferentiated uveitis, 31.7% infectious, 25.7% juvenile idiopathic arthritis-associated uveitis, and 10.2% other non-infectious uveitis. At presentation, 79.0% had none to mild VI, 12.6% moderate VI, and 8.4% severe VI to blindness. On generalized estimating equations analysis for individual eyes, prior oral steroids and older age were risk factors, while female gender, prior topical corticosteroids and immunosuppressive therapy were protective against moderate and/or severe VI.
Conclusions: Over a fifth of pediatric uveitis cases present with moderate/severe VI, especially in older age or with prior oral corticosteroid therapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/09273948.2024.2401134 | DOI Listing |
Cureus
August 2025
General Internal Medicine and Nephrology, Robert Bosch Krankenhaus, Stuttgart, DEU.
Tubulointerstitial nephritis and uveitis (TINU) syndrome is a rare autoimmune condition primarily affecting adolescents. Diagnosis is frequently delayed due to the nonspecific and temporally dissociated presentation of renal and ocular symptoms. We report the case of a 15-year-old girl who presented to her general practitioner with fatigue, polyuria, and recent weight loss.
View Article and Find Full Text PDFFront Pediatr
August 2025
Department of Pediatrics, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.
Background: Blau Syndrome is a rare monogenic disorder characterized by granulomatous polyarthritis, dermatitis, and uveitis. The diagnosis can be challenging as symptoms may not always align with the classic triad.
Case Description: An 8-year-old girl presented with fluctuant swellings in the wrists and ankles, strength reduction and stiffness.
JAMA Ophthalmol
August 2025
Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
Importance: Emerging evidence suggests that glucagon-like peptide-1 receptor agonists (GLP-1RAs), commonly used for glycemic control in diabetes, may possess anti-inflammatory properties. Understanding their potential protective role against uveitis could provide insights into novel therapeutic strategies.
Objective: To evaluate whether being prescribed a GLP-1RA is associated with a reduced risk of developing uveitis.
Expert Rev Gastroenterol Hepatol
August 2025
Division of Gastroenterology, Center for Autoimmune Liver Diseases, European Reference Network on Hepatological Diseases (ERN RARE-LIVER), IRCCS Fondazione San Gerardo Dei Tintori, Monza, Italy.
Introduction: Inflammatory Bowel Diseases (IBD) are chronic immune-mediated disorders diagnosed in both adult and pediatric populations. In recent years, there has been a significant global increase in pediatric-onset IBD, not only in Western countries but also in newly industrialized regions. Age of onset plays a crucial role in disease behavior and prognosis, with pediatric onset often associated with a more extensive and aggressive disease.
View Article and Find Full Text PDFOcul Immunol Inflamm
August 2025
Department of Medical Biochemistry, Faculty of Medicine, Al-Azhar University, Nasr City, Cairo, Egypt.
Purpose: To fully characterize the clinical and pathological characteristics of PTIGU (Presumed Trematode-Induced Granulomatous) in pediatric patients and therefore enhance its diagnostic accuracy and treatment modalities.
Methods: A retrospective descriptive observational study was conducted at the specialized uveitis clinic of MIKE (Memorial Institute for Kids' Eye unit), Memorial Institute for Ophthalmic Research, Giza, Egypt. The study involved 125 eyes of 105 children diagnosed with PTIGU.